US EditionVaxess Raises $9M in Funding
Summary by FinSMEs
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Vaxess Raises $9M in Funding
Vaxess, a Woburn, MA-based biotech company developing microarray patch technology, raised $9M in funding. Backers included RA Capital Management and Engine Ventures. The company intends to use the funds to advance its work in GLP-1, and expand manufacturing capabilities to support the lead program and new partnerships for additional therapeutics. Led by CEO Rachel Sha, […] The post Vaxess Raises $9M in Funding appeared first on FinSMEs.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
